Clinical Trials Browser

OTHER × Thromboembolism × Gemcitabine × Clear all

NCT02921022 2025-11-26

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Phase NA Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

NCT00031837 2015-10-14

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism